University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 24 of 35
Methadone Oxytocin Option
NCT01728909
A Mobile Based Diabetes Prevention Program
NCT01579292
Providing "Good Sleep" for ICU Sedation
NCT01342328
Delayed Start to Ovarian Stimulation
NCT01614067
Perioperative Propranolol in Patients With Post Traumatic Stress Disorder (PTSD)
NCT01555554
CAMBRA - PBRN Caries Management By Risk Assessment In A Practice-Based Research Network
NCT01176396
Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D
NCT01877577
Healthy Mood Internet Recruitment Study
NCT01607164
Assessment of Bone Micro-Architecture Using HR-pQCT
NCT01367730
Characterization and Treatment of Chemotherapy Neuropathy
NCT01557608
Bone Quality by vQCT and HR-pQCT:Translation to Multi-center Clinical Research
NCT01544660
Comparison of Pain of Conventional to Buffered Local Anesthesia During Injection in Pediatric Dental Patients
NCT01622296
Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
NCT01554371
Improving Care of Patients With Heart Failure
NCT01461681
The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment
NCT01511315
AANCART Research Project on Lay Health Workers and Asian Americans
NCT01904890
Drug Interaction Study of Clopidogrel and Rosuvastatin
NCT01469416
Running Against Prehypertension Trial (RAPT): A Pilot Trial
NCT01587183
Dynamic Cardiac SPECT Imaging
NCT01934985
UCSF Research Participant Registry
NCT01717378
Lay Health Worker Outreach in Increasing Colorectal Cancer Screening in Asian Americans
NCT03115372
Open Label Clinical Trial of Vitamin D in Children With Autism
NCT01535508
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
NCT01535235
Ancillary T Cell Based Studies in SPIROMICS
NCT02036190
Oxytocin MEG Study
NCT02568709
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
NCT01463046
Integrative Approaches for Cancer Survivorship
NCT01488123
Menopausal Treatment Using Relaxation Exercises (MaTURE)
NCT01466998
Role of microRNAs in T Cell-Driven Inflammation in Asthma
NCT01484691
Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers
NCT01508832
Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation
NCT01581164
Clinical Diagnosis of Acute Porphyria
NCT01568554
Drug-Drug Interaction Study With Pravastatin and Cyclosporine
NCT01497483
Mindfulness-Based Cognitive Therapy Effect on Depression and C-Reactive Protein Levels After 8 Weeks of Treatment
NCT02385786
Post-operative Sore Throat as Determined by Endotracheal Tube Inflation Technique
NCT01305265
Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
NCT01396343
Prenatal Education About Reducing Labor Stress (PEARLS)
NCT02327559
Prospective Femoral Versus Femoral and Sciatic Nerve Block for Anterior Cruciate Ligament (ACL) Reconstruction
NCT01447277
Treatment for the Mental Health Impact of Killing in War
NCT01406834
Effects of Sleep, Fatigue, and Timing of Post-dates Inductions Among Nulliparas
NCT01542151
Drug-drug Interaction Study With Metformin and Imatinib
NCT01404715
Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide
NCT01452854
Simons Variation in Individuals Project, Functional Common Acquisition Protocol
NCT01527578
Drug-Drug Interaction Study With Metformin and Nizatidine
NCT01409395
Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging
NCT01741246
Study of Tomography of Nephrolithiasis Evaluation
NCT01451931
Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors
NCT01474954
The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance
NCT01412216
The Total Health Study
NCT01415206
Effects of Gastric pH on the Pharmacokinetics of Dasatinib
NCT01398046
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.